Effects of calcium and amino acids on gut hormone secretions and bone turnover in healthy males
- Conditions
- Healthy human gastrointestinal physiologyHealthy human bone turnover physiologyDiet and Nutrition - ObesityOral and Gastrointestinal - Normal oral and gastrointestinal development and functionMetabolic and Endocrine - Normal metabolism and endocrine development and functionMusculoskeletal - Normal musculoskeletal and cartilage development and function
- Registration Number
- ACTRN12620001294943
- Lead Sponsor
- Christine Feinle-Bisset
- Brief Summary
Intraduodenal administration of calcium enhances the effect of Trp to suppress energy intake, associated with greater stimulation of GI hormones secretion, in health.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 15
Healthy
Lean weight (BMI 19-25 kg/m2)
Each participant will be questioned prior to the study to exclude:
-significant GI symptoms, disease or surgery
-use of prescribed or non-prescribed medications (including vitamins and herbal supplements) which may affect energy metabolism, GI function, body weight or appetite (e.g. domperidone, cisapride, anticholinergic drugs (e.g. atropine), metoclopramide, erythromycin, hyoscine, orlistat, green tea extracts, Astragalus, St Johns Wort etc.)
-lactose intolerance/other food allergy(ies)
-current gallbladder or pancreatic disease
-cardiovascular or respiratory diseases
-individuals with low ferritin levels (females <15 ng/mL, males <30 ng/mL), or who have donated blood in the 12 weeks prior to taking part in the study
-any other illnesses as assessed by the investigator (including chronic illnesses not explicitly listed above)
-high performance athletes
-current intake of > 2 standard drinks on > 5 days per week
-current smokers of tobacco (cigarettes, cigars, pipes, sheesha, chewing, vaping etc.)
- recreational drug use, e.g marijuana
-current intake of any illicit substance
-vegetarians
-inability to tolerate nasoduodenal tube
-inability to comprehend study protocol
-restrained eaters (score >12 on the 3-factor eating questionnaire)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method